Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 2051 results found since Jan 2013.
Prevention of Shingles in Dermatology Patients on Systemic Medications
Skin Therapy Lett. 2023 Jul;28(4):4-6.ABSTRACTThe lifetime risk for herpes zoster (HZ) of approximately 1 in 3 is increased with advancing age, a family history of HZ, diseases with altered immune function, immunosuppression, physical trauma and psychological stress. In dermatology, monotherapy with current biologics does not increase risk, however systemic steroids, Janus kinase inhibitors and combination biologic/conventional disease-modifying antirheumatics do. The recombinant zoster vaccine (RZV, Shingrix®), an adjuvanted non-live subunit vaccine against the glycoprotein E subunit of varicella zoster virus, is approve...
Source: Skin Therapy Letter - July 13, 2023 Category: Dermatology Authors: Lyn Guenther Source Type: research
